Anticoagulation therapy associated with improved survival among COVID-19 patients

Anticoagulation therapy associated with improved survival among COVID-19 patients

Anticoagulation therapy associated with improved survival among COVID-19 patients

Early in the COVID-19 pandemic, Mount Sinai researchers were among the first to show that anticoagulation therapy was associated with improved survival among hospitalized COVID-19 patients